Evidence map›Paper›PMID 32387786›Full record

ReviewWorld neurosurgery2020

Neurological Impact of Coronavirus Disease of 2019: Practical Considerations for the Neuroscience Community.

Cassidy Werner, Tyler Scullen, Mansour Mathkour, Tyler Zeoli, Adam Beighley, Mitchell D Kilgore, Christopher Carr, Richard M Zweifler, Aimee Aysenne, Christopher M Maulucci and 3 more

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in World neurosurgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Neurological involvement associated with COVID-19 disease: a study on psychosocial factors.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  6. Article
  7. Article
  8. Neuropsychiatric Disorders and COVID-19: What We Know So Far.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  9. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  10. Article
  11. Incidence, clinical characteristics, risk factors and outcomes of meningoencephalitis in patients with COVID-19.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Neurological manifestations of COVID-19 infection: an umbrella review.The Egyptian journal of neurology, psychiatry and neurosurgery · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Electroencephalogram (EEG) in COVID-19: A systematic retrospective study.Neurophysiologie clinique = Clinical neurophysiology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Cassidy WernerDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA.
Tyler ScullenDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA; Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Mansour MathkourDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA; Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Tyler ZeoliDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA.
Adam BeighleyDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA.
Mitchell D KilgoreDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA.
Christopher CarrDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA.
Richard M ZweiflerDepartment of Neurology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Aimee AysenneDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA.
Christopher M MaulucciDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA; Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Aaron S DumontDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA; Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Cuong J BuiDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA; Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Joseph R KeenDepartment of Neurosurgery, Tulane Medical Center, New Orleans, Louisiana, USA; Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, Louisiana, USA. Electronic address: Joseph.keen@ochsner.org.
Ochsner Medical Center · USTulane Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease of 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently been designated a pandemic by the World Health Organization, affecting 2.7 million individuals globally as of April 25, 2020, with more than 187,000 deaths. An increasing body of evidence has supported central nervous system involvement.

methodsWe conducted a review of the reported data for studies concerning COVID-19 pathophysiology, neurological manifestations, and neuroscience provider recommendations and guidelines.

resultsCentral nervous system manifestations range from vague nonfocal complaints to severe neurological impairment associated with encephalitis. It is unclear whether the neurological dysfunction results from direct viral injury or systemic disease. The virus could affect brainstem pathways that lead to indirect respiratory dysfunction, in addition to direct pulmonary injury. Necessary adaptations in patient management, triage, and diagnosis are evolving in light of the ongoing scientific and clinical findings.

conclusionsThe present review has consolidated the current body of data regarding the neurological impact of coronaviruses, discussed the reported neurological manifestations of COVID-19, and highlighted the recommendations for patient management. Specific recommendations pertaining to clinical practice for neurologists and neurosurgeons have also been provided.

Indexed as

BetacoronavirusAdultAgedCoronavirus InfectionsCOVID-19FemaleHumansMaleMiddle AgedNervous System DiseasesNeurosciencesPandemicsPneumonia, ViralSARS-CoV-2COVID-19EncephalitisGuidelineNeuroscienceSARS-COV-2

Identifiers

PMID32387786
PMCPMC7202815
OpenAlexW3023566562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.